NUWE Stock Analysis: Buy, Sell, or Hold?
NUWE - Nuwellis, Inc. Common Stock
$1.16
0.04 (3.57%)
▲
5d:
-11.45%
30d:
-47.27%
90d:
+16.41%
HOLD
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When NUWE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NUWE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NUWE shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NUWE is currently trading at $1.16, which is considered slightly low relative to its 30-day fair value range of $1.15 to $2.69.
Technical Outlook: Technically, NUWE is in a uptrend. Immediate support is located at $1.11, while resistance sits at $1.55. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: NUWE scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $11.00 (+848.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NUWE is in a uptrend. Immediate support is located at $1.11, while resistance sits at $1.55. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: NUWE scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $11.00 (+848.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.15 -
$2.69
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.6%)
- BULLISH: Trading 848.3% below Wall St target ($11.00)
- CAUTION: Bottoming setup, but lagging the sector by 43% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-11.5%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.15 -
$2.69
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.11
Resistance Level
$1.55
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.84
Wall Street Target
$11.00
(+848.3%)
Revenue Growth (YoY)
14.1%
Earnings Growth (YoY)
-99.2%
Profit Margin
-125.6%
Share & Embed Analysis
Last updated: August 24, 2026 2:15 AM ET
Data refreshes hourly during market hours. Next update: 3:15 AM
Data refreshes hourly during market hours. Next update: 3:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NUWE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 31 SELL |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 35 SELL |
